Medical Marijuana Study: 70 percent of CBD products inaccurately labelled - Americans for Safe Access
Americans for Safe Access Co-Author’s Study in JAMA on Cannabidiol Products
Washington, DC - A new study published this week in JAMA found that nearly 70 percent of all cannabidiol (CBD) products sold online are either over or under labeled, causing potential serious harm to its consumers. The study, co-authored by Jahan Marcu, Ph.D, American’s for Safe Access’ (ASA) Chief Science Officer and Director of Patient Focused Certification (PFC), analyzed 84 CBD products available online from 31 companies.
“This is a wake up call for the CBD industry to standardize their products,” said Dr. Marcu, “CBD product manufacturers need to adopt best practices and accept guidance from AHPA and other groups to improve consistency and safety for consumers. Reaching compliance with existing standards for cannabis-products could help address this issue.”
Americans for Safe Access Launches Campaign and Declares November 1: National Cannabis as an Option for Pain Day
WASHINGTON, DC — On November 1, Americans for Safe Access, the US Pain Foundation, and approximately 150 advocates will hold a press conference and rally in Washington to encourage Congress and the Administration to consider medical cannabis as an option for pain in order to help mitigate the current opioid overdose crisis that has hit epidemic proportions in our nation. Sister rallies are planned across the country. See AFI list below.
Trump Declares Opioid Crisis a Public Health Emergency, but Falls Short on Substance - Americans for Safe Access
Americans for Safe Access to Launch National Campaign to Combat Opioid Deaths and Addiction Nov 1st
WASHINGTON, DC — Today, President Trump declared the opioid crisis a public health emergency. While this is good news, this declaration does not carry the same weight as the national emergency declaration the President promised in August because it does not include the necessary provisions for new funds which states need to combat the crisis. Nor does the Administration have a substantive plan for helping the states implement a concerted effort to combat the crisis.
(Prague, 16th October 2017) International Cannabis and Cannabinoids Institute (ICCI) welcomes Ethan Russo, MD as the new Director of Research and Development. ICCI is the first-ever international Center of Excellence for the advancement of cannabis and cannabinoid treatments located in the Czech Republic. ICCI identifies, coordinates, and supports global research priorities for the advancement of cannabis and cannabinoid treatments through a multidiscipline evidence-based approach that incorporates innovative tools and approaches.
Councilmember David Grosso Sets Example for Local Leadership in Opioid Crisis - Americans for Safe Access
Washington D.C. — District of Columbia Councilmember David Grosso introduced improvements to the nation’s capitol’s medical cannabis program yesterday, recognizing the power of cannabis to fight the opioid crisis. The Medical Marijuana Improvement Amendment Act of 2017 reduces major barriers that previously existed in D.C.’s medical cannabis program. Councilmember Grosso is joined by Councilmembers Vincent Grey, Robert White, Jr., and Brianne Nadeau in introducing this important bill.
The legislation, which shares components of model legislation drafted by Americans for Safe Access, increases access to medical cannabis for the residents of the District of Columbia - particularly those who struggle with chronic pain. Significantly, it allows a patient to receive cannabis on the same day a patient is issued a doctor’s recommendation, like any other medicine, and allows for delivery of medical cannabis. It also allows a patient without a primary care physician to self-certify a medical condition through a signed affidavit. Low income patients who struggle to pay for doctor's visits will particularly benefit from these provisions.
U.S. House Committee on Rules Blocks Rohrabacher-Blumenauer Amendment
Washington D.C. -- Last night, the House Committee on Rules voted to not allow a floor vote on an amendment which would continue to prevent the Department of Justice from using funds to interfere with state medical marijuana programs. The amendment, introduced by Representatives Dana Rohrabacher (R-CA) and Earl Blumenauer (D-OR) has been part of the appropriations package since 2015.
Massachusetts Medical Society Promotes Cannabis Education for Medical Professionals, Patient Advocates Hail Effort as a Huge Step Forward
The Massachusetts Medical Society, a leader in continuing medical education (CME) providing accredited and certified activities across the globe for physicians and other health care professionals, endorsed the TheAnswerPage.com Comprehensive Cannabis Curriculum, as their comprehensive curriculum on the endocannabinoid system and medical cannabis. This is among the highest validations for an endocannabinoid and medical cannabis curriculum.
U.S. Senate Committee on Appropriations Votes on Leahy Amendment
Washington D.C. -- This morning, the Senate Committee on Appropriations voted to include an amendment introduced by Senator Patrick Leahy (D-VT) in the FY2018 Commerce, Justice, Science and Related Agencies Appropriations bill. The amendment prohibits the use of Federal funds to interfere with medical cannabis patients and programs that are in compliance with state medical cannabis laws.
Patient Organization Discourages Changes to the Cole Memo
Washington D.C. -- The Department of Justice’s marijuana subcommittee of the Crime Reduction and Public Safety Task Force was scheduled to issue recommendations to the Attorney General by July 27. However, according to the Justice Department these recommendations have been ongoing and will become available to the public as they are submitted. One item under potential review is the Cole Memorandum.
Washington D.C. -- This morning, the Senate Committee on Appropriations voted 24-7 to include an amendment introduced by Senators Steve Daines (R-MT) and Jeff Merkley (D-OR) in the FY2018 Military Construction, Veterans Affairs Appropriations bill. The amendment allows military veterans to participate in state medical cannabis programs without fear of losing their military benefits or services and enables Department of Veterans Affairs health care providers to recommend medical cannabis in compliance with state medical cannabis laws.